"The partners have an excellent grasp of commercialization issues as operational executives and consultants."

- Triangle Insights

Group Client

Engagements focused on decisions to optimally commercialize or invest in specific individual assets

Case Study: Biosimilar Opportunity Assessment

Client Situation

Emerging biopharmaceutical company needed to establish the commercial case for a specific oncology biosimilar it was developing in order to validate further clinical investment and ultimately prepare for partnering discussions.

Triangle Insights Approach

  • Market Landscape: Developed thorough market landscape assessment for relevant cancer indication, including epidemiology, current treatment algorithms, and an overview of products in development.
  • Biosimilar Landscape: Synthesized secondary research to refine understanding of biosimilars landscape, including early launch performance of select biosimilars in Europe.
  • Primary Research: Conducted primary research with US and EU oncologists and payers to understand receptivity to biosimilars in cancer.
  • Forecast Model: Developed revenue forecast / net present value models for client's biosimilar under various launch scenarios.
  • Insights: Presented project findings to company's executive leadership team


Client made strategic decision to re-allocate investment based on key finding that payers were unwilling to drive utilization of biosimilars for a treatment that potentially extended survival, leaving biosimilar use to the discretion of treating oncologists.